Innovation Showcase

The Oncolytic Virotherapy Innovation Showcase 2022

PLEASE FILL IN THEE FORM BELOW TO SUBMIT YOUR APPLICATION TO PRESENT 

DEADLINE TO SUBMIT: NOVEMBER 24

The innovation showcase aims to demonstrate the latest innovations from the field, where emerging oncolytic virus start-ups and emerging companies with an active drug-discovery pipeline will have the opportunity to pitch and present their company to the entire audience, demonstrating the opportunity they can bring to market.

 

This will be a short presentation in front of the entire audience, whereby you can showcase your companies work. This can be data-driven, to showcase a snippet of your latest work, or a perspective to showcase novel platforms/approaches. Through this, we are hoping to offer the opportunity for our attendees to exhibit the array of promising work towards development of Oncolytic Virotherapies.

Our platform is about giving a voice to the innovation that will catapult OV in into the future and putting that in front of the decision-makers that can accelerate that vision.

 

Finalists chosen by our Selection Committee will present their company on the Boston stage this December in a quick-fire round of presentations!

*If you are one of the chosen finalists to take part in the Innovation Showcase, you must register as a paying attendee to the summit

Companies Who Have Joined Our Summit in the Past:

Pfizer_(2021)
AstraZeneca-Logo.wine
Takeda_logo_logotype
Janssen_Pharmaceuticals_logo.svg
Astellas_logo_logotype
Genentech.svg
Bristol-Myers_Squibb_logo_(2020).svg
1200px-Boehringer_Ingelheim_Logo.svg
amgen
1280px-Merck_Logo.svg
Bayer-Logo.wine
800px-AbbVie_logo.svg
192-1921487_bluebird-bio-bluebird-bio-inc-logo